Rituximab in refractory Wegener's granulomatosis: Favorable or not? [3]

Peer M. Aries; Peter Lamprecht; Wolfgang L. Gross

Rituximab in refractory Wegener's granulomatosis: Favorable or not? [3]

Peer M. Aries^*, Peter Lamprecht, Wolfgang L. Gross

^*Corresponding author for this work

Clinic of Rheumatology

University of Kiel

11 Citations (Scopus)

Original language	English
Journal	American Journal of Respiratory and Critical Care Medicine
Volume	173
Issue number	7
Pages (from-to)	815-816
Number of pages	2
ISSN	1073-449X
Publication status	Published - 01.04.2006

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{be5c0dee17ca41ad8933ed4788d9296f,

title = "Rituximab in refractory Wegener's granulomatosis: Favorable or not? [3]",

author = "Aries, {Peer M.} and Peter Lamprecht and Gross, {Wolfgang L.}",

year = "2006",

month = apr,

day = "1",

language = "English",

volume = "173",

pages = "815--816",

journal = "American Journal of Respiratory and Critical Care Medicine",

issn = "1073-449X",

number = "7",

}

TY - JOUR

T1 - Rituximab in refractory Wegener's granulomatosis: Favorable or not? [3]

AU - Aries, Peer M.

AU - Lamprecht, Peter

AU - Gross, Wolfgang L.

PY - 2006/4/1

Y1 - 2006/4/1

UR - http://www.scopus.com/inward/record.url?scp=33645286185&partnerID=8YFLogxK

M3 - Letters

C2 - 16556703

AN - SCOPUS:33645286185

SN - 1073-449X

VL - 173

SP - 815

EP - 816

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

IS - 7

ER -

Rituximab in refractory Wegener's granulomatosis: Favorable or not? [3]

Research Areas and Centers

UN SDGs

Other files and links

Cite this